Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.
3.
4.
5.
6.
7.
8.

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

Tebbey PW, Scheuer CA, Peek JA, Zhu D, LaPierre NA, Green BA, Phillips ED, Ibraghimov AR, Eldridge JH, Hancock GE.

Vaccine. 2000 Jun 1;18(24):2723-34.

PMID:
10781860
9.

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.

Power UF, Plotnicky-Gilquin H, Huss T, Robert A, Trudel M, Ståhl S, Uhlén M, Nguyen TN, Binz H.

Virology. 1997 Apr 14;230(2):155-66.

11.

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.

Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.

Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002.

12.

Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice.

Liang XP, Lamm ME, Nedrud JG.

Reg Immunol. 1989 Jul-Aug;2(4):244-8.

PMID:
2561961
13.

Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA.

Wyatt LS, Whitehead SS, Venanzi KA, Murphy BR, Moss B.

Vaccine. 1999 Oct 14;18(5-6):392-7.

PMID:
10519927
14.

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE.

Vaccine. 2007 Oct 10;25(41):7132-44.

PMID:
17850933
15.
16.

BBG2Na an RSV subunit vaccine candidate intramuscularly injected to human confers protection against viral challenge after nasal immunization in mice.

Goetsch L, Plotnicky-Gilquin H, Aubry JP, De-Lys P, Haeuw JF, Bonnefoy JY, Nguyen NT, Corvaïa N, Velin D.

Vaccine. 2001 Jul 16;19(28-29):4036-42.

PMID:
11427280
17.
18.
19.

The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.

Hancock GE, Hahn DJ, Speelman DJ, Hildreth SW, Pillai S, McQueen K.

Vaccine. 1994;12(3):267-74.

PMID:
8165859
20.

Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate.

Goetsch L, Plotnicky-Gilquin H, Champion T, Beck A, Corvaïa N, Stâhl S, Bonnefoy JY, Nguyen TN, Power UF.

Vaccine. 2000 Jun 1;18(24):2735-42.

PMID:
10781861
Items per page

Supplemental Content

Support Center